Abdollahi, M. & Radfarl, M. (2003). A review of drug-induced oral reactions. Journal of Contemporary Dental Practice, 4, 10–31.
Abelson, J., Treloar, C., Crawford, J., Kippax, S., Van Beek, I. & Howard, J. (2006). Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction, 101, 548–555.
Aceijas, C., Stimson, G., Hickman, M. & Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS, 18, 2295–2303.
Aderjan, R., Hoemann, S., Schmitt, G. & Skopp, G. (1995). Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. Journal of Analytical Toxicology, 19, 163–168.
Agrawal, A. & Lynskey, M. (2008). Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction, 103, 1069–1081.
Agrawal, A., Neale, M. C., Prescott, C. A. & Kendler, K. S. (2004). Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behavior Genetics, 34, 217–228.
Ahmadi, J. (2003). Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients. Journal of Substance Abuse Treatment, 24, 217–220.
Ahmadi, J., Arabi, H. & Mansouri, Y. (2003). Prevalence of substance use among offspring of opioid addicts. Addictive Behaviors, 28, 591–595.
Aitken, C., Kerger, M. & Crofts, N. (2000). Drivers who use illicit drugs: behaviour and perceived risks. Drugs: Education, Prevention and Policy, 7, 39–50.
Albery, I., Gossop, M., Strang, J. & Griffiths, P. (2000). Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug and Alcohol Dependence, 58, 197–204.
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn. Text Revision). Washington, DC: American Psychiatric Association.
Anglin, M. D., Brecht, M. L., Woodward, J. A. & Bonett, D. G. (1986). An empirical study of maturing out: conditional factors. International Journal of the Addictions, 21, 233–246.
Anglin, M. D., Speckart, G. R, Booth, M. W. & Ryan, T. M. (1989). Consequences and costs of shutting off methadone. Addictive Behaviors, 14, 307–326.
Anglin, M. D., Hser, Y. I. & Grella, C. E. (1997). Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11, 308–323.
Anthony, J. C., Warner, L. & Kessler, R. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.
AntoliniG., Pirani, M., Morandi, G. & Sorio, C. (2006). Gender differnce and mortality in a cohort of heroin users in the provinces of Modena and Ferrara, 1975–1999. Epidemiologia e Preventione, 30, 91–99.
Appleby, L., Cooper, J., Amos, T. & Faragher, B. (1999). Psychological autopsy study of suicides by people under 35. British Journal of Psychiatry, 175, 168–174.
Arriola, K. R. J., Louden, T., Doldren, M. A. & Fortenberry, R. M. (2005). A meta-analysis of the relationship of child sexual abuse to HIV risk behavior among women. Child Abuse and Neglect, 29, 725–746.
Athanasiadus, L. (1999). Drugs, alcohol and violence. Current Opinion in Psychiatry, 12, 281–286.
Auriacombe, M., Franque, P. & Tignol, J. (2001). Deaths attributable to methadone vs. buprenorphine in France. Journal of American Medical Association, 285, 45.
Australian Institute of Health and Welfare. (2008). 2007 National Household Survey: Detailed Findings. Drug Statistics Series No. 16. Canberra: Australian Institute of Health and Welfare.
Azim, T., Chowdhury, E. I., Reza, M.et al. (2008). Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle/syringe exchange program in Dhaka. Bangladesh Substance Use and Misuse, 43, 2124–2144.
Baca, C. T. & Grant, K. J. (2007). What heroin users tell us about overdose. Journal of Addictive Diseases, 26, 63–68.
Backmunda, M., Schuetzb, C., Meyera, K., Edlinc, B. R. & Reimer, J. (2009). The risk of emergency room treatment due to overdose in injection drug users. Journal of Addictive Diseases, 28, 68–73.
Bailey, R. C., Hser, Y. I. & Anglin, H. (1994). Influences affecting maintenance and cessation of narcotics addiction. Journal of Drug Issues, 24, 249–272.
Balakireva, O. & Grund, J. P. (2006). Risk and Protective Factors in the Initiation of Injecting Drug Use. Kiev: UNAIDS.
Ball, J. C. & Ross, A. (1991). The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome. Vienna: Springer-Verlag.
Bammer, G. (2009). Treating heroin dependence with diamorphine (pharmaceutical heroin). In R. P. Mattick., R. Ali. & N. Lintzeris. (eds.) Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-effectiveness, and Implementation Guidelines, pp. 54–106. New York: Informa Healthcare.
Bargagli, A. M., Sperati, A., Davoli, F., Forastiere, F. & Perucci, C. A. (2001). Mortality among problem drug users in Rome: an 18-year follow-up study, 1980–1997. Addiction, 96, 1455–1463.
Bargagli, A. M., Faggiano, F., Amato, L.et al. (2006). VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population. Substance Use and Misuse, 41, 1861–1879.
Bargagli, A. M., Hickman, M., Davoli, M.et al. (2006). Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health, 16, 198–202.
Bartholomew, N. G., Courtney, K., Rowan-Szal, G. A. & Simpson, D. D. (2005). Sexual abuse history and treatment outcomes among women undergoing methadone treatment. Journal of Substance Abuse Treatment, 29, 231–235.
Bartu, A., Freeman, N. C., Gawthorne, G. S., Allsop, S. J. & A. J. (2002). Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone. Drug and Alcohol Review, 21, 335–340.
Bartu, A., Freeman, N. C., Gawthorne, G. S., Codde, J. P. & Holman, D. J. (2004). Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction, 99, 63–60.
Bastos, F. I. & Strathdee, S. (2000). Evaluating effectivness of syringe exchange programmes: current issues and future prospects. Social Science and Medicine, 51, 1771–1782.
Bauer, S. M., Loiple, R., Jagsch, R.et al. (2008). Mortality in opioid-maintained patients after release from an addiction clinic. European Addiction Research, 14, 82–91.
Bell, J., Shanahan, M., Mutch, C.et al. (2007). A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine–naloxone for heroin dependence. Addiction, 102, 1899–1907.
Bennett, G. & Higgins, D. (1999). Accidental overdose among injecting drug users in Dorset, UK. Addiction, 94, 1179–1190.
Bertelote, J. M. & Fleischmann, A. (2002). A global perspective in the epidemiology of suicide. Suicidologi, 7, 6–8.
Best, D., Gossop, M., Lehmann, P., Harris, J. & Strang, J. (1999). The relationship between overdose and alcohol consumption among methadone maintenance patients. Journal of Substance Use, 4, 41–44.
Best, D., Gossop, M., Man, L., Stillwell, G., Coomber, R. & Strang, J. (2002). Peer overdose resuscitation: multiple intervention strategies and time to response by drug users who witness overdose. Drug and Alcohol Review, 21, 269–274.
Beynon, C. M., Roe, B., Duffy, P. & Pickering, L. (2009). Self reported health status, and health service contact, of illicit drug users aged 50 and over: a qualitative interview study in Merseyside, United Kingdom. BMC Geriatrics, 9, 45.
Bird, S. M. (2010). Over 1200 drugs-related deaths and 190,000 opiate-users-years of follow-up: relative risks by sex and age group. Addiction Research and Theory, 18, 194–207.
Bjornaas, M. A., Bekken, A. S., Ojlert, A.et al. (2008). A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry, 8, 1–8.
Bobashev, G. V. & Anthony, J. C. (1998). Clusters of marijuana use in the United States. American Journal of Epidemiology, 148, 1168–1174.
Boeri, M. W., Sterk, C. E. & Eklifson, K. W. (2008). Reconceptualizing early and late onset: a life course analysis of older heroin users. The Gerontologist, 48, 637–645.
Boles, S. M. & Miotto, K. (2003). Substance abuse and violence: a review of the literature. Aggression and Violent Behaviour, 8, 155–174.
Borges, G., Walters, E. E. & Kessler, R. C. (2000). Associations of substance use, abuse, and dependence with subsequent suicidal behaviour. American Journal of Epidemiology, 151, 781–789.
Botvin, G. & GriffinK. W. (2007). School-based programs to prevent alcohol, tobacco and other drug use. International Review of Psychiatry, 19, 607–15.
Boyd, J., Randell, T., Luurila, H. & Kuisma, M. (2003). Serious overdoses involving buprenorphine in Helsinki. Acta Anaestiologica Scandinavia, 47, 1031–1033.
Bradley, R. H. & Corwyn, R. F. (2002). Socioeconomic status and child development. Annual Review of Psychology, 53, 371–399.
Brådvik, L., Hulenvik, P., Frank, A., Medvedeo, A. & Berglund, M. (2007). Self-reported and observed heroin overdoses in Malmoe. Journal of Substance Use, 12, 119–126.
Braitstein, P., Lia, K., Tyndall, M.et al. (2003). Sexual violence among a cohort of injection drug users. Social Science & Medicine, 57, 561–569.
Branstetter, S. A., Bower, E. H., Kamien, J. & Amass, L. (2008). A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment. Journal of Substance Abuse Treatment, 34, 208–214.
Breslau, N. N., Scott, P. & Kessler, R. C. (2004). Psychiatric disorders and stages of smoking. Biological Psychiatry, 55, 69–76.
Brienza, R. S., Stein, M. D., Chen, M. H.et al. (2000). Depression among needle exchange and methadone maintenance clients. Journal of Substance Abuse Treatment, 18, 331–337.
Britton, P. C., Wines, J. D. & Conner, K. R. (2010). Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug and Alchol Dependence, 107, 51–55.
Broome, K. M., Joe, G. W. & Simpson, D. D. (1999). Patient and program attributes related to treatment process indicators in DATOS. Drug and Alcohol Dependence, 57, 127–135.
Brooner, R. K., Greenfield, L., Schmidt, C. W. & Bigelow, G. E. (1993). Antisocial personality disorder and HIV infection in drug abusers. American Journal of Psychiatry, 150, 53–58.
Brugal, M. T., Barrio, G., de la Fuente, L.Regidor, E., Royuela, L. & Suelves, J. M. (2002). Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction, 97, 319–327.
Brugal, M. T., Domingo-Salvany, A., Puig, R.et al. (2005). Evaluating the impact of methadone maintenance programmes on mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction, 100, 981–989.
Bryant, W. K., Galea, S., Tracy, M., Piper, T. M., Tardiff, K. J. & Vlahov, D. (2003). Overdose deaths attributed to methadone and heroin in New York City, 1990–1998. Addiction, 99, 846–854.
Budd, J., Copeland, L., Elton, R. & Robertson, R. (2002). Hepatitis C infection in a cohort of injecting drug users: past and present risk factors and the implications for educational and clinical management. European Journal of General Practice, 8, 95–100.
Bull, S. S., Piper, P. & Rietmeijer, C. (2002). Men who have sex with men and also inject drugs – profiles of risk related to the synergy of sex and drug injection behaviors. Journal of Homosexuality, 42, 31–51.
Burns, J. M., Martyres, R. F., Clode, D. & Boldero, J. M. (2004). Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances. Medical Journal of Australia, 181, S25–S28.
Burns, L., Conroy, E. & Mattick, R. P. (2010). Infant mortality among women on a methadone program during pregnancy. Drug and Alcohol Review, 29, 551–556.
Buster, M. C. A., Rook, L., van Brussel, H. A., van Ree, J. & van den Brink, W. (2002). Chasing the dragon related to impaired lung function among heroin users. Drug and Alcohol Dependence, 68, 221–228.
Cacciola, J. S., Alterman, A. I., Rutherford, M. J., McKay, J. R. & Mulvaney, F. D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence, 61, 271–280.
Calabria, B., Degenhardt, L., Briegleb, C.et al. (2010). Systematic review of prospective studies investigating ‘remission’ from amphetamine, cannabis, cocaine or opioid dependence. Addictive Behaviors, 35, 741–749.
Carpenter, M. J., Chutuape, M. A. & Stitzer, M. L. (1998). Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug and Alcohol Dependence, 53, 11–15.
Carpentier, P. J., Krabbe, P. F. M., van Gogh, M. T., Knapen, L. J. M., Buitelaar, J. K. & de Jong, C. A. J. (2009). Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. The American Journal on Addictions, 18, 470–480.
Carise, D., Dugosh, K. L., McLellan, A. T., Camilleri, A., Woody, G. E. & Lynch, K. G. (2007). Prescription oxycontin abuse among patients entering addiction treatment. American Journal of Psychiatry, 164, 1750–1756.
Cecile, J.S, Alderman, A.I, Rutherford, M.J, McKay, J. R. & Mulvane, F. D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Dependence, 61, 271–280.
Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A. & Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association, 261, 561–565.
Chatham, L. R., Knight, K., Joe, G. W. & Simpson, D. D. (1995). Suicidality in a sample of methadone maintenance patients. American Journal of Drug and Alcohol Abuse, 21, 345–361.
Chen, K. & Kandel, D. B. (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health, 85, 41–47.
Chen, V. C., Lin, T. Y., Lee, C. T.et al. (2010). Suicide attempts prior to starting methadone maintenance treatment in Taiwan. Drug and Alcohol Dependence 109, 139–143.
Chiang, S., Chua, Chen, S. J., Sun, H. J., Chan, H. Y. & Chen, W. J. (2006). Heroin use among youths incarcerated for illicit drug use: psychosocial environment, substance use history, psychiatric comorbidity, and route of administration. The American Journal on Addictions, 15, 233–241.
Cicchetti, D. & Rogosch, F. A. (1999). Psychopathology as risk for adolescent substance use disorders: a developmental psychopathology perspective. Journal of Clinical Child Psychology, 28, 355–365.
Cicero, T., Inciardi, J. & Muñoz, A. (2005). Trends in abuse of oxycontin® and other opioid analgesics in the United States: 2002–2004. Journal of Pain, 6, 662–672.
City of Vancouver. (2008). Methadone becoming a nursing-home drug. Four Pillars News. City of Vancouver For Pillars Coalition Newsletter. September, 2008.
Clark, D. B., Thatcher, D. L. & Tapert, S. F. (2008). Alcohol, psychological dysregulation, and adolescent brain development. Alcoholism: Clinical Experimental Research, 32, 378–385.
Clark, H. W., Masson, C. L., Deluchi, K. L., Hall, S. M. & Sees, K. L. (2001). Violent traumatic events and drug abuse severity. Journal of Substance Abuse Treatment, 20, 121–127.
Clarke, T. K., Krause, K., Li, T. & Schumann, G. (2009). An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Biology, 14, 366–370.
Clausen, T., Anchersen, K. & Waal, H. (2008). Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug and Alcohol Dependence, 94, 151–157.
Clausen, T., Waal, H, Thoresen, M. & Gossop, M. (2009). Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction, 104, 1356–1362.
Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D., Vlahov, D. & Galea, S. (2007). Identifying injecting drug users at risk of non-fatal overdose. Academic Emergency Medicine, 14, 616–623.
Collins, D., Lapsley, H. & Marks, R. (2007). The Three Billion $ Question for Australian Business. Sydney: Australian Drug Law Reform Foundation.
Conroy, E.,Degenhardt, L.,Mattick, R. P. & Nelson, E. C. (2009). Child maltreatment as a risk factor for opioid dependence: comparison of family characteristics and type and severity of child maltreatment with a matched control group. Child Abuse and Neglect, 33, 343–352.
Cook, S., Moeschler, O., Michaud, K. & Yersin, B. (1998). Acute opiate overdose: characteristics of 190 consecutive cases. Addiction, 93, 1559–1569.
Coomber, R. (1999). The cutting of heroin in the United States in the 1990s. Journal of Drug Issues, 29, 17–36.
Cooncool, B., Smith, H. & Stimmel, B. (1979). Mortality rates of persons entering methadone maintenance: a seven-year study. American Journal of Drug and Alcohol Abuse, 6, 345–353.
Costello, E., Erkanli, A., Federman, E. & Angold, A. (1999). Development of psychiatric comorbidity with substance abuse in adolescents: effects of timing and sex. Journal of Clinical Child Psychology, 28, 298–311.
Cottler, L. B., Compson, W. M., Mager, D., Spitznagel, E. L. & Janca, A. (1992). Posttraumatic stress disorder among substance abusers from the general population. American Journal of Psychiatry, 149, 664–670.
Courtwright, D., Joseph, H. & Des Jarlais, D. (1989). Addicts Who Survived: An Oral History of Narcotic Addiction in America 1923–1965. Knoxville: University of Tennessee.
Coviello, D. M., Alterman, A. I., Cacciola, J. S., Rutherford, M. J. & Zanis, D. A. (2004). The role of family history in addiction severity and treatment response. Journal of Substance Abuse Treatment, 26, 1–11.
Cox, G. & Comiskey, C. M. (2007). Baseline characteristics of patients attending treatment for opiate use in Ireland. Drugs: Education, Prevention and Policy, 14, 217–230.
Crofts, N., Louie, R., Rosenthal, D. & Jolley, D. (1996). The first hit: circumstances surrounding initiation into injecting. Addiction, 91, 1187–1196.
Crofts, N., Aitken, C. & Kaldor, J. (1999). The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia, 170, 220–221.
Cross, J. C., Saunders, C. & Bartelli, D. (1998). The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity, 32, 165–180.
CuijpersP. (2002). Effective ingredients of school-based drug prevention programs. A systematic review. Addictive Behaviors, 27, 1009–23.
Cumming, S., Covic, T. & Murrell, E. (2006). Deliberate self-harm: have we scratched the surface?Behaviour Change, 23, 186–99.
Curran, C., Byrappa, N. & McBride, A. (2004). Stimulant psychosis: systematic review. British Journal of Psychiatry, 185, 196–204.
Cynan, J., Trunsky, M. & Cobridge, T. (2000). Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest, 117, 272–275.
Daniel, A. Z., Hickman, M.,McLeod, Jet al. (2009) Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. Drug and Alcohol Review, 28, 142–153.
Darke, S. (2010). The toxicology of homicide offenders and victims: a review. Drug and Alcohol Review, 29, 202–215.
Darke, S. & Duflou, J. (2008). Toxicology and circumstances of death of homicide victims in New South Wales, Australia 1996–2005. Journal of Forensic Sciences, 53, 447–451.
Darke, S. & Hall, W. (2003). Heroin overdose: research and evidence-based intervention. Journal of Urban Health, 80, 189–200.
Darke, S. & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48, 135–141.
Darke, S & Ross, J. (2000). Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction, 95, 596–599.
Darke, S. & Ross, J. (2001). The relationship between suicide and overdose among methadone maintenance patients in Sydney, Australia. Addiction, 96, 1443–1453.
Darke, S. & Ross, J. (2002). Suicide among heroin users: rates, risk factors and methods. Addiction, 97, 1383–1394.
Darke, S., Ross, J. & Hall, W. (1996a). Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug and Alcohol Dependence, 43, 191–198.
Darke, S., Ross, J. & Hall, W. (1996b). Overdose among heroin users in Sydney, Australia I. Prevalence and correlates of non-fatal overdose. Addiction, 91, 405–411.
Darke, S., Ross, J. & Hall, W. (1996c). Overdose among heroin users in Sydney, Australia II. Responses to overdose. Addiction, 91, 413–417.
Darke, S., Sunjic, S., Zador, D. & Prolov, T. (1997). A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug and Alcohol Dependence, 47, 45–53.
Darke, S., Kaye, S. & Finlay-Jones, R. (1998). Antisocial personality disorder, psychopathy and injecting drug use. Drug and Alcohol Dependence, 52, 63–69.
Darke, S., Hall, W., Weatherburn, D. & Lind, B. (1999a). Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug and Alcohol Dependence, 54, 155–161.
Darke, S., Kaye, S. & Ross, J. (1999b). Transitions between the injection of heroin and amphetamines. Addiction, 94, 1795–1803.
Darke, S., Ross, J., Zador, D. & Sunjic, S. (2000). Heroin-related deaths in New South Wales, Australia, 1992–1996. Drug and Alcohol Dependence, 60, 141–150.
Darke, S., Kaye, S. & Ross, J. (2001a). Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction, 96, 241–246.
Darke, S., Ross, J. & Kaye, S. (2001b). Physical injecting sites among injecting drug users in Sydney, Australia. Drug and Alcohol Dependence, 62, 77–82.
Darke, S., Hall, W., Kaye, S., Ross, J. & Duflou, J. (2002a). Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction, 97, 977–984.
Darke, S., Topp, L. & Ross, J. (2002b). The injection of methadone and benzodiazepines among Sydney IDU 1996–2000: 5 year monitoring of trends from the Illicit Drug Reporting System (IDRS). Drug and Alcohol Review, 21, 35–40.
Darke, S., Kelly, E. & Ross, J. (2003a). Drug use and driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions. Addiction, 99, 175–185.
Darke, S., Mattick, R. & Degenhardt, L. (2003b). The ratio of non-fatal to fatal overdose. Addiction, 98, 1169–1170.
Darke, S., Ross, J. & Lynskey, M. (2003c). The relationship of conduct disorder to attempted suicide and drug use history among methadone maintenance patients. Drug and Alcohol Review, 22, 21–25.
Darke, S., Hetherington, K., Ross, J., Lynskey, M. & Teesson, M. (2004a). Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug and Alcohol Review, 23, 177–183.
Darke, S., Ross, J., Lynskey, M. & Teesson, M. (2004b). Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Drug and Alcohol Dependence, 73, 1–10.
Darke, S., Williamson, A., Ross, J., Teesson, M. & Lynskey, M. (2004c). Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 74, 77–83.
Darke, S., Kaye, S. & Duflou, J. (2005a). Cocaine-related fatalities in New South Wales, Australia 1993–2002. Drug Alcohol Dependence, 77, 107–114.
Darke, S., Ross, J. & Teesson, M. (2005b). Twelve month outcomes for heroin dependence treatments: does route of administration matter?Drug and Alcohol Review, 24, 165–171.
Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A. & Lynskey, M. (2005c). Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 28, 255–263.
Darke, S., Ross, J., Williamson, A. & Teesson, M. (2005d). The impact of Borderline Personality Disorder on 12 month outcomes for the treatment of heroin dependence. Addiction, 100, 1121–1130.
Darke, S., Kaye, S. & Duflou, J. (2006a). Systemic disease among cases of fatal opioid toxicity. Addiction, 101, 1299–1305.
Darke, S., Williamson, A., Ross, J. & Teesson, M. (2006b). Residential rehabilitation for the treatment of heroin dependence: sustained heroin abstinence and drug-related problems two years after treatment entrance. Addictive Disorders and Their Treatment, 5, 9–18.
Darke, S., Williamson, A., Ross, J. & Teesson, M. (2006c). Reductions in heroin use are not associated with increases in other drug use: two year findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence, 84, 201–205.
Darke, S., Degenhardt, L. & Mattick, R. (2007a). Mortality Amongst Illicit Drug Users: Epidemiology, Causes and Intervention. Cambridge: Cambridge University Press.
Darke, S., Havard, A., Ross, J., Williamson, A., Mills, K. L. & Teesson, M. (2007b). Changes in the use of medical services and prescription drugs amongst heroin users over two years. Drug and Alcohol Review, 26, 153–159.
Darke, S., Ross, J., Mills, K. L., Williamson, A., Havard, A. & Teesson, M. (2007c). Borderline Personality Disorder and persistently elevated levels of risk in 36 month outcomes. Addiction, 102, 1140–1146.
Darke, S., Ross, J., Mills, K. L., Williamson, A., Havard, A. & Teesson, M. (2007d). Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Addictive Behaviors, 32, 1897–1906.
Darke, S., Ross, J., Williamson, A., Mills, K. L., Havard, A. & Teesson, M. (2007e). Patterns of non-fatal heroin overdose over a three year period: findings from the Australian Treatment Outcome Study. Journal of Urban Health, 84, 283–291.
Darke, S., Ross, J., Williamson, A., Mills, K. L., Havard, A. & Teesson, M. (2007f). Patterns and correlates of attempted suicide by heroin users over a three year period: findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence, 87, 146–152.
Darke, S., Kaye, S., McKetin, R. & Duflou, J. (2008a). The major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27, 253–262.
Darke, S., Ross, J., Mills, K. L., Williamson, A., Havard, A. & Teesson, M. (2008b). Injecting and non-injecting heroin administration: transitions and treatment outcomes across 36 months. Journal of Drug Issues, 38, 543–558.
Darke, S., Duflou, J. & Torok, M. (2009a). Toxicology and circumstances of completed suicide by means other than overdose. Journal of Forensic Sciences, 54, 490–494.
Darke, S., Mills, K. L., Ross, J., Teesson, M.,Williamson, A. & Havard, A. (2009b). Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatric Research, 166, 7–14.
Darke, S., Mills, K. L., Ross, J., Williamson, A., Havard, A. & Teesson, M. (2009c). The ageing heroin user: career length, clinical profile and outcomes across 36 months. Drug and Alcohol Review, 28, 243–249.
Darke, S., Duflou, J. & Torok, M. (2010a). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 106, 1–6.
Darke, S., Duflou, J. & Torok, M. (2010b). Comparative toxicology of intentional and accidental heroin overdose. Journal of Forensic Sciences, 55, 1015–1018.
Darke, S., Ross, J., Mills, K., Teesson, M.,Williamson, A. & Havard, A. (2010c). Benzodiazepine use amongst heroin users: baseline use, current use and clinical outcome. Drug and Alcohol Review, 29, 250–255.
Darke, S., Torok, M., Kaye, S., & Ross, J. (2010d). Attempted suicide, self-harm and violent victimisation amongst regular illicit drug users. Suicide and Life-Threatening Behavior, 40, 587–596.
Darke, S., Torok, M., Kaye, S., Ross, J. & McKetin, R. (2010e). Comparative rates of violent crime amongst regular methamphetamine and opioid users: offending and victimisation. Addiction, 105, 916–919.
Darke, S., Duflou, J. & Torok, M. (2011). Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999–2008. Journal of Forensic Sciences, 54, 490–494.
Darke, S., Mills, K. L., Ross, J. & Teesson, M. (in press b). Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug and Alcohol Dependence.
Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R. & Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80, 261–273.
Davoli, M., Perucci, C. A., Rapiti, E.et al. (1997). A persistent rise in mortality among injection drug users in Rome, 1980 through 1992. American Journal of Public Health, 87, 851–853.
Davoli, M., Bargagli, A. M., Perucci, C. A.et al. (2007). Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multisite prospective cohort study. Addiction, 102, 1954–1959.
Day, C., Degenhardt, L., Gilmour, S. & Hall, W. (2004). Effects of a reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. British Medical Journal, 329, 428–429.
Dean, A., Bell, J., Christie, M. J. & Mattick, R. P. (2004). Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. European Psychiatry, 19, 510–513.
Degenhardt, L. & Hall, W. (2002). Cannabis and psychosis. Current Psychiatry Reports, 4, 191–196.
Degenhardt, L., Lynskey, M. & Hall, W. (2000). Cohort trends in the age of initiation of drug use in Australia. Australian and New Zealand Journal of Public Health, 24, 421–426.
Degenhardt, L., Hall, W. & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37–48.
Degenhardt, L., Hall, W., Warner-Smith, M. & Lynskey, M. (2004). Illicit drug use. In M. Ezzati, A. Lopez, A. Rodgers, & C. J. L. Murray. (eds.) Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Vol 1, pp. 1111–1175. Geneva: World Health Organization.
Degenhardt, L., Tennant, C., Gilmour, S.et al. (2007). The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychological Medicine, 37, 927–934.
Degenhardt, L., Kinner, S., Roxburgh, A.et al. (2008). Drug use and risk among regular injecting drug users in Australia: does age make a difference?Drug and Alcohol Review, 27, 357–360.
Degenhardt, L., Chiu, W. T., Conway, K.et al. (2009a). Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Psychological Medicine, 39, 157–167.
Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T. & Burns, L. (2009b). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug and Alcohol Dependence, 105, 9–15.
Degenhardt, L., Dierkerb, L., Chiu, W. T.et al. (2010). Evaluating the drug use ‘gateway’ theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alchol Dependence, 108, 84–97.
Degenhardt, L., Bucello, C., Mathers, B.et al. (2011). Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction, 106, 32–51.
de la Fuente, L., Saavedra, P., Barrio, G., Royuela, L. & Vicente, J. (1996). Temporal geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug and Alcohol Dependence, 40, 185–194.
DeLeon, G., Melnick, G. & Cleland, C. (2008). Client matching: a severity-treatment intensity paradigm. Journal of Addictive Disorders, 27, 99–111.
De los Cobos, J. P. (2007). Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. Drug and Alcohol Dependence, 89, 190–194.
DeMaria, P. A., Sterling, R. & Weinstein, S. P. (2000). The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal of Addiction, 9, 145–153.
Desmond, D. P., Maddux, J. F. & Trevino, A. (1978). Street heroin potency and deaths from overdose in San Antonio. American Journal of Drug and Alcohol Abuse, 5, 39–49.
Dettmer, K., Saunders, B. & Strang, J. (2001). Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. British Medical Journal, 322, 895–896.
Deykin, E. Y. & Buka, S. L. (1994). Suicidal ideation and attempts among chemically dependent adolescents. American Journal of Public Health, 84, 634–639.
Dhossche, D. M., Rich, C. L., Ghani, S. O. & Isacson, G. (2001). Patterns of psychoactive substance detection from routine toxicology of suicides in Mobile, Alabama, between 1990 and 1998. Journal of Affective Disorders, 64, 167–174.
Diekstra, R. F. W. (1996). The epidemiology of suicide and parasuicide. Archives of Suicide Research, 2, 1–29.
Digiusto, E., Shakeshaft, A., Ritter, A., O'Brien, S., Mattick, R. P. & the-NEPOD-Research-Group (2004). Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction, 99, 450–460.
Dinwiddie, S. H., Cottler, L., Compton, W. & Abdallah, A. B. (1996). Psychopathology and HIV risk behaviours among injection drug users in and out of treatment. Drug and Alcohol Dependence, 43, 1–11.
Doherty, M. C., Garfein, R. S., Monterroso, E., Brown, D. & Vlahov, D. (2000). Correlates of HIV infection among young adult short-term injection drug users. AIDS, 14, 717–726.
Dolan, K., Shearer, J., MacDonald, M., Mattick, R. P., Hall, W. & Wodak, A. D. (2003). A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug and Alcohol Dependence, 72, 59–65.
Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J. & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction, 100, 820–828.
Dole, V. P. & Nyswander, M. E. (1965). Medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. Journal of the American Medical Association, 193, 646–650.
Dole, V. P., Nyswander, M. E. & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118, 304–309.
Drakenberg, K., Nikoshkov, A., Horvath, M. C.et al. (2006). mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proceedings of the National Academy of Sciences, 103, 7883–7888.
Dube, S. R., Anda, R. F., Whitfield, C. L.et al. (2005). Long-term consequences of childhood sexual abuse by gender of victim. American Journal of Preventive Medicine, 28, 430–438.
Ellgren, M., Spano, S. M. & Hurd, Y. L. (2007). Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology, 32, 607–615.
European Monitoring Centre for Drugs and Drug Addiction (2010). Annual Report on the State of the Drugs Problem in Europe. Lisbon: EMCDDA.
Evren, C. & Evren, B. (2005). Self-mutilation in substance-dependent patients and relationship with childhood abuse and neglect, alexithymia and temperament and character dimensions of personality. Drug and Alcohol Dependence, 80, 15–22.
Fairbank, J. A., Dunteman, G. H. & Condelli, W. S. (1993). Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. American Journal of Drug and Alcohol Abuse, 19, 465–474.
Fajemirokun-Odudeyi, O., Sinha, C., Tutty, S.et al. (2006). Pregnancy outcome in women who use opiates. European Journal of Obstetrics and Gynecology and Reproductive Biology, 126, 170–175.
Farrell, M. & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103, 251–255.
Farrell, M., Boys, A., Bebbington, P.et al. (2002). Psychosis and drug dependence: results from a national survey of prisoners. British Journal of Psychiatry, 181, 393–398.
Farrugia, P., Mills, K. L., Barrett, E.et al. (in press). Childhood trauma among individuals with co-morbid substance use and post traumatic stress disorder. Mental Health & Substance Use: Dual Diagnosis.
Fast, D.Small, W.Wood, E. & Kerr, T. (2008). The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduction Journal, 5, 32.
Fergus, S. & Zimmerman, M. A. (2005). Adolescent resilience: a framework for understanding healthy development in the face of risk. Annual Review of Public Health, 26, 399–419.
Fergusson, D. M. & Horwood, L. J. (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92, 279–296.
Fergusson, D. M. & Horwood, L. J. (2000). Does cannabis use encourage other forms of illicit drug use?Addiction, 95, 505–520.
Fergusson, D. M. & Lynskey, M. T. (1995). Childhood circumstances, adolescent adjustment, and suicide attempts in a New Zealand Birth Cohort. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 612–622.
Fergusson, D. M. & Lynskey, M. T. (1997). Physical punishment/maltreatment during childhood and adjustment in young adulthood. Child Abuse and Neglect, 21, 617–630.
Fergusson, D. M., Lynskey, M. T. & Horwood, L. J. (1993). Conduct problems and attention deficit behaviour in middle childhood and cannabis use by age 15. Australian and New Zealand Journal of Psychiatry, 27, 673–682.
Fergusson, D. M., Horwood, L. J. & Lynskey, M. T. (1994a). Parental separation. Adolescent psychopathology, and problem behaviors. Journal of the American Academy of Child and Adolescent Psychiatry, 338, 1122–1131.
Fergusson, D. M., Horwood, L. J. & Lynskey, M. T. (1994b). The comorbidities of adolescent problem behaviors. A latent class model. Journal of Abnormal Child Psychology, 22, 339–353.
Fergusson, D. M., Horwood, L. J. & Lynskey, M. T. (1994c). The childhoods of multiple problem adolescents: a 15-year longitudinal study. Journal of Child Psychology and Psychiatry, 35, 1123–1140.
Fergusson, D. M., Lynskey, M. T. & Horwood, L. J. (1994d). Childhood exposure to alcohol and adolescent drinking patterns. Addiction, 89, 1007–1016.
Fergusson, D. M., Boden, J. M. & HorwoodL. J. (2006). Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction, 101, 556–569.
Ferri, M., Bargagli, A. M., Faggiano, F.et al. (2007). Mortality of drug users attending public treatment centers in Italy 1998–201: a cohort study. Epidemiologia e Preventione, 31, 276–282.
Fineschi, V. & Masti, A. (1996). Poisoning by MDMA (ecstasy) and MDEA: a case report. International Journal of Legal Medicine, 108, 272–275.
Firoz, S. & Carlson, G. (2004). Characteristics and treatment outcome of older methadone-maintenance patients. American Journal of Geriatric Psychiatry, 12, 539–541.
Fischer, B., Brissette, S., Brochu, S.et al. (2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association Journal, 171, 235–239.
Fite, P. J., Wynn, P., Lochman, J. E. & Wells, K. C. (2009). The influence of neighborhood disadvantage and perceived disapproval on early substance use initiation. Addictive Behaviors, 34, 769–771.
Fleming, J.Mullen, P. E., Sibthorpe, B., Attewell, R. & Bammer, G. (1998). The relationship between childhood sexual abuse and alcohol abuse in women – a case-control study. Addiction, 93, 1787–1798.
Flynn, P. M., Joe, G. W., Broome, K. M., Simpson, D. D. & Brown, B. S. (2003). Recovery from opioid addiction in DATOS. Journal of Substance Abuse Treatment, 25, 177–186.
Forrester, M. B. (2007). Oxycodone abuse in Texas, 1998–2004. Toxicology and Environmental Health, 70, 534–538.
Foxcroft, D., Ireland, D., Lister-Sharp, D., Lowe, G. & Breen, R. (2003). Longer-term primary prevention for alcohol misuse in young people: a systematic review. Addiction, 98, 397–411.
Freeman, R. C., Parillo, K. M., Collier, K. & Rusek, R. W. (2001). Child and adolescent sexual abuse history in a sample of 1,490 women sexual partners of injection drug-using men. Women and Health, 34, 31–49.
Friedman, L.S., Hyman, S. E. & Fleming, N. (1996). Source Book of Substance Abuse and Addiction. Maryland: Williams & Wilkins.
Fugelstad, A., Rajs, J., Bottiger, M., Gehrardsson, M. & de Verdier, M. G. (1995). Mortality among HIV-infected intravenous addicts in Stockholm in relation to methadone treatment. Addiction, 90, 711–716.
Fugelstad, A., Ahlner, J., Brandt, L.et al. (2003). Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction, 98, 463–470.
Fugelstad, A., Stenbacka, M., Leifman, A.,Nylander, M. & Thiblin, I. (2007). Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction, 102, 406–412.
Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A. & Strathdee, S. A. (2002). High-risk behaviours associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug and Alcohol Dependence, 66, 189–198.
Gable, R. S. (1993). Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used non-medically. American Journal of Drug and Alcohol Abuse, 19, 263–281.
Galea, S., Ahern, J., Vlahov, D.et al. (2003). Income distribution and risk of fatal overdose in New York City neighbourhoods. Drug and Alcohol Dependence, 70, 139–178.
Galea, S., Nandi, V. V. & Vlahov, D. (2004). The social epidemiology of substance use. Epidemiologic Reviews, 26, 36–52.
Galea, S., Worthington, N., Piper, T. M., Nandi, V. V., Curtis, M. & Rosenthal, D. M. (2006). Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addictive Behaviors, 31, 907–912.
Garofalo, R., Wolf, R. C., Kessel, S., Palfrey, J. & DuRant, R. H. (1998). The association between health risk behaviors and sexual orientation among a school-based sample of adolescents. Pediatrics, 101, 895–902.
Gelkopf, M., Bleich, A., Hayward, R., Dodner, G., Adelson, M. (1999). Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug and Alcohol Dependence, 55, 63–68.
Gerstley, L. J., Alterman, A. I., McLellan, A. T., & Woody, G. E. (1990). Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis?, American Journal of Psychiatry, 147, 173–178.
Ghitza, U. E., Epstein, D. H. & Preston, K. L. (2008). Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug and Alcohol Dependence, 97, 150–157.
Gibbs, S. J., BeautraisA. L. & Fergusson, D. M. (2005). Mortality and further suicidal behaviour after an index suicide attempt: a 10-year study. Australian and New Zealand Journal of Psychiatry, 39, 95–100.
Gibson, A. & Degenhardt, L. (2007). Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. Drug and Alcohol Review, 26, 405–410.
Gibson, A. & Ritter, A. (2009). Naltrexone maintenance treatment. In R. P. Mattick, R. Ali. & N. Lintzeris. (eds.) Pharmacotherapies for the Treatment of Opioid Dependence. Efficacy, Cost-effectiveness, and Implementation Guidelines, pp. 252–281. New York: Informa Healthcare.
Gibson, D., Flynn, N. & Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behaviour and HIV seroconversion among injecting drug users. AIDS, 15, 1329–1341.
Gilbert, L., El-Bassel, N., Schilling, R. F. & Friedman, E. (1997). Childhood abuse as a risk for partner abuse among women in methadone maintenance. American Journal of Drug and Alcohol Abuse, 23, 581–595.
Gill, J. R. (2001). Fatal descent from height in New York City. Journal of Forensic Sciences, 46, 1132–1137.
Gill, J. R. & Catanese, C. (2002). Sharp injury fatalities in New York City. Journal of Forensic Sciences, 47, 554–557.
Gil-Rivas, V., Fiorentine, R., Anglin, M. D. & Taylor, E. (1997). Sexual and physical abuse: do they compromise drug treatment outcomes?Journal of Substance Abuse Treatment, 14, 351–358.
Glatt, S., Bousman, C., Wang, R.et al. (2007). Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug and Alcohol Dependence, 90, 159–165.
Goddard, E. (2008). General Household Survey 2006: Smoking and Drinking among Adults. London: Office for National Statistics.
Godfrey, C., Stewart, D. & Gossop, M. (2004). Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction, 99, 697–707.
Goldberg, R. J. & Grabowski, R. (2003). Methadone maintenance: its future in skilled nursing facilities. Journal of the American Medical Directors Association, 4, 98–100.
Goldman, D., Oroszi, G. & Ducci, F. (2005). The genetics of addictions: uncovering the genes. Nature Reviews Genetics, 6, 521–532.
Goldstein, A. & Herrara, J. (1995). Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug and Alcohol Dependence, 40, 139–150.
Goldstein, P. J. (1985). The drugs/violence nexus: a tripartite conceptual framework. Journal of Drug Issues, 14, 493–506.
Golub, A. & Johnson, B. D. (2002). Substance use progression and hard drug use in inner-city New York. In D. B. Kandel. (ed.) Stages and Pathways of Drug Involvement. Examining the Gateway Hypothesis, pp. 90–114. Cambridge: Cambridge University Press.
Goodman, L. S. & Gilman, A. G. (1996). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw Hill.
Goodwin, R. D., Fergusson, D. M. & Horwood, L. J. (2004). Association between anxiety disorders and substance use disorders among young persons: results of a 21-years longitudinal study. Journal of Psychiatric Research, 38, 295–304.
Goren, N. (2005). Social Marketing: Prevention and Practice Review. Melbourne: Centre for Youth Drug Studies, Australian Drug Foundation.
Gossop, M. & Moos, R. (2008). Substance misuse among older adults: a neglected but treatable problem. Addiction, 103, 347–348.
Gossop, M., Bradley, B. & Phillips, G. T. (1987). An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day inpatient methadone detoxification procedure, Addictive Behaviors, 12, 1–6.
Gossop, M., Griffiths, P., Powis, B. & Strang, J. (1992). Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction, 87, 1527–1536.
Gossop, M, Griffiths, P, Powis, B, Williamson, S. & Strang, J. (1996). Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. British Medical Journal, 313, 402.
Gossop, M., Marsden, J., Stewart, D.et al. (1998). Substance use, health and social problems of service users at 54 drug treatment agencies: intake data from the national treatment outcome research study. British Journal of Psychiatry, 193, 166–171.
Gossop, M., Marsden, J., Stewart, D. & Rolfe, A. (1999). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57, 89–98.
Gossop, M., Marsden, J., Stewart, D. & Rolfe, A. (2000). Patterns of improvement after methadone treatment: 1 year's follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence, 60, 275–286.
Gossop, M., Marsden, J., Stewart, D. & Treacy, S. (2002a). Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study. Addictive Behaviours, 27, 155–166.
Gossop, M., Steward, D., Treacy, S. & Marsden, J. (2002b). A prospective study of mortality among drug misusers during a four year period after seeking treatment. Addiction, 97, 39–47.
Graham, H. & Power, C. (2004). Childhood disadvantage and health inequalities: a framework for policy based on lifecourse research. Child Care: Health and Development, 30, 671–678.
Grant, B. F. & Dawson, D. A. (1998). Age of onset and its association with DSM-IV drug abuse and dependence: results form the National Longitudinal Alcohol Epidemiological Survey. Journal of Substance Abuse, 10, 163–173.
Grau, L. E., Dasgupta, N., Harvey, A. P.et al. (2007). Illicit use of opioids: is oxycontin a ‘Gateway Drug’?The American Journal on Addictions, 16, 166–173.
Greenberg, M., Hamilton, R. & Toscano, G. (1999). Analysis of toxicology reports from the 1993–1994 census of fatal occupational injuries. Compensation and Working Conditions, 4, 26–28.
Griffiths, P., Gossop, M., Powis, B. & Strang, J. (1994). Transitions in patterns of heroin administration: a study of heroin chasers and injectors. Addiction, 89, 301–309.
GuichardA., LertF., CalderonC.et al. (2003). Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction, 98, 1585–1597.
Gutierrez-Cebollada, J., De La Torre, R., Ortuno, J., Garces, J. & Cami, J. (1994). Psychotropic drug consumption and other factors associated with heroin overdose. Drug and Alcohol Dependence, 35, 169–174.
Haarstrup, S. & Jepson, P. W. (1988). Eleven year follow-up of 300 young opioid addicts. Acta Psychiatrica Scandinavia, 77, 22–26.
Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M. & Naber, D. (2007). Heroin-assisted treatment for opioid dependence randomised controlled trial. British Journal of Psychiatry, 191, 55–62.
Hagan, H., Des Jarlais, D. C., Stern, R.et al. (2007). HCV Synthesis Project: preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18, 341–351.
Hahesy, A. L., Wilens, T. E., Biederman, J., Van Patten, S. L. & Spencer, T. (2002). Temporal association between childhood psychopathology and substance. Psychiatry Research, 109, 245–253.
Haile, C. N., Kosten, T. A. & Kosten, T. R. (2008). Pharmacogenetic treatments for drug addiction: alcohol and opiates. American Journal of Drug and Alcohol Abuse, 34, 355–381.
Hall, W., Bell, J. & Carless, J. (1993). Crime and drug use among applicants for methadone maintenance. Drug and Alcohol Dependence, 31, 123–129.
Hall, W., Johnston, L. & Donnelly, N. (1999). Epidemiology of cannabis use and its consequences. In H. Kalant, W. Corrigall, W. Hall & R. Smart. (eds.) The Health Effects of Cannabis, pp. 71–125. Toronto: Centre for Addiction and Mental Health.
Hallinan, R., Byrne, A., Amin, J. & Dore, G. J. (2005). Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. Journal of Gastroenterology and Hepatology, 20, 1082–1086.
Hamilton, A. B. & Grella, C. E. (2009). Gender differences among older heroin users. Journal of Women and Aging, 21, 111–124.
Harned, M. S., Najavitis, L. M. & Weiss, R. D. (2006). Self-harm and suicidal behaviour in women with comorbid PTSD and substance dependence. The American Journal on Addictions, 15, 392–5.
Harris, E. C. & Barraclough, B. (1997). Suicide as an outcome for mental disorders. British Journal of Psychiatry, 170, 205–228.
Harris, E. C. & Barraclough, B. (1998). Excess mortality of mental disorder. British Journal of Psychiatry, 173, 11–53.
Hartel, D. M., Schoenbaum, E. E., Lo, Y. & Klein, R. S. (2006). Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clinical and Infectious Dieases, 43, 525–531.
Hartnoll, R. L., Mitcheson, M. C., Battersby, A.et al. (1980). Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry, 37, 877–884.
Harwood, H., Fountain, D. & Livermore, G. (1998). Economic Costs of Alcohol and Drug Abuse in the United States, 1992. Bethesda MD: National Institutes of Health.
Hassan, R. (1995). Suicide Explained. The Australian Experience. Melbourne: Melbourne University Press.
Hatzitaskos, P., Soldatos, C. R., Kokkevi, A. & Stefanis, C. N. (1999). Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder. Comprehensive Psychiatry, 40, 278–282.
Hawkins, J., Catalano, R. & Miller, J. (1992). Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychological Bulletin, 112, 64–105.
Havard, A., Teesson, M., Darke, S. & Ross, J. (2006). Depression among heroin users: 12 month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 30, 355–362.
Heffernan, K., Cloitre, M., Tardiff, K., Marzuk, P., Portera, L. & Leon, A. (2000). Childhood trauma as a correlate of lifetime opiate use in psychiatric patients. Addictive Behaviors, 25, 797–803.
Hemmingsson, T., Lundberg, I., Romelsjo, A. & Alfredsson, L. (1997). Alcoholism in social classes and occupations in Sweden. International Journal of Epidemiology, 26, 584–591.
Hemstrom, O. (2002). Alcohol-related deaths contribute to socioeconomic differentials in mortality in Sweden. European Journal of Public Health, 12, 254–262.
Henry, B., Feehan, M., McGee, R., Stanton, W., Moffitt, T. & Silva, P. (1993). The importance of conduct problems and depressive symptoms in predicting adolescent substance use. Journal of Abnormal Child Psychology, 21, 469–480.
Herbert, J. R., Nichols, S. E. & Kabat, G. C. (1990). Indicators of nutritional status among clients from a New York City methadone treatment center. Journal of Substance Abuse Treatment, 7, 161–165.
Hickman, M., Madden, P., Henry, J.et al. (2003). Trends in drug overdose deaths in England and Wales 1993–1998: methadone does not kill more people than heroin. Addiction, 98, 419–425.
Hien, D. A., Nunes, E., Levin, F. R. & Fraser, D. (2000). Posttraumatic stress disorder and short-term outcome in early methadone treatment. Journal of Substance Abuse Treatment, 19, 31–37.
Hoda, Z., Kerr, T., Li, K., Montaner, J. S. G. & Wood, E. (2008). Prevalence and correlates of jugular injections among injection drug users. Drug and Alcohol Review, 27, 442–446.
Hodgins, S., Cree, A., Alderton, J. & Mak, T. (2008). From conduct disorder to severe mental illness: associations with aggressive behaviour, crime and victimization. Psychological Medicine, 38, 975–987.
Horwood, L. J., Fergusson, D. M., Hayatbakhsh, M. R.et al. (2010). Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug and Alcohol Dependence, 110, 247–253.
Hser, Y. (2007). Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up. Journal of Addictive Diseases, 26, 51–60.
Hser, Y., Grella, C., Chou, C. P. & Anglin, M. D. (1998). Relationship between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Evaluation Review, 22, 496–519.
Hser, Y., Grella, C. E., Hsieh, S., Anglin, M. D. & Brown, B. S. (1999). Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence, 57, 137–150.
Hser, Y., Hoffman, V., Grella, C. & Anglin, M. D. (2001). A 33-year follow-up of narcotic addicts. Archives of General Psychiatry, 58, 503–508.
Hser, Y., Gelberg, L., Hoffman, V.et al. (2004). Health conditions among aging narcotics addicts: medical examination results. Journal of Behavioral Medicine, 27, 607–622.
Hser, Y., Hunag, D., Chou, C. & Anglin, M. D. (2007a). Trajectories of heroin addiction. Growth mixture modelling results based on a 33-year follow-up study. Evaluation Review, 6, 548–563.
Hser, Y., Longshore, D. & Anglin, M. D. (2007b). The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Evaluation Review, 6, 515–547.
Hubbard, R. L., Marsden, M., Rachal, J., Harwood, H., Cavanaugh, E. & Ginzburg, H. (1989). Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill: University of North Carolina Press.
HubbardR. L., Craddock, S. G., Flynn, P. M., Anderson, J. & Etheridge, R. M. (1997). Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviours, 11, 261–278.
Humeniuk, R., Ali, R., McGregor, C. & Darke, S. (2003). Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction, 98, 413–418.
Inciardi, J. A. & Harrison, L. D. (eds.) (1998). Heroin in the Age of Crack-Cocaine. CA: Sage Publications.
JenkinsonR., ClarkN. C., FryC. L. & DobbinM. (2005). Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction, 100, 197–205.
Joe, G. W. & Simpson, D. D. & Broome, K. M. (1998). Effects of readiness to change for drug abuse treatment on client retention and assessment of process. Addiction, 93, 1177–1190.
Joe, G. W., Broome, K. M. & Simpson, D. D. (1999). Retention and patient engagement in models for different treatment modalities in DATOS. Drug and Alcohol Dependence, 57, 113–125.
Johnson, R. A. & Gerstein, D. R. (1998). Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. American Journal of Public Health, 88, 27–33.
Johnson, R. A. & Gerstein, D. R. (2000). Age, period, and cohort effects in marijuana and alcohol incidence: United States females and males, 1961–1990. Substance Use and Misuse, 35, 925–948.
Johnsson, E. & Fridell, M. (1997). Suicide attempts in a cohort of drug abusers: a five year follow-up study. Acta Psychiatrica Scandinavia, 96, 362–366.
Johnston, A., Pirkis, J. & Burgess, P. M. (2009). Suicidal thoughts and behaviours among Australian adults: findings from the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 43, 635–643.
Kakkoa, J., Heiliga, M. & Sarman, I. (2008). Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug and Alcohol Dependence, 96, 69–78.
Kalyoncu, A., Mırsal, H., Pektaş, O., Tan, D. & Beyazyürek, M. (2007). Heroin-dependent patients attempting and not attempting suicide: a comparison. Acta Neuropsychiatrica, 19, 297–303.
Kandel, D. (1975). Sequences and stages in adolescent drug use. Science, 190, 912–914.
Kandel, D. B. (1984). Marijuana users in young adulthood. Archives of General Psychiatry, 41, 200–209.
Kandel, D. (1991). The social demography of drug use. Milbank Quarterly, 69, 365–414.
Kandel, D. B. (ed.) (2002). Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Cambridge: Cambridge University Press.
Kandel, D. B. & Yamaguchi, K. (1999). Developmental stages of involvemnt in substance use. In R. E. Tarter, R. T. Ammerman & P. Ott. Sourcebook on Substance Abuse: Etiology, Epidemiology, Assessment, and Treatment, pp. 50–74. Needham: Alleyn & Bacon.
Kandel, D. B. & Yamaguchi, K. (2002). Stages of drug involvement in the US population. In D. B. Kandel. (ed.) Stages and Pathways of Drug Involvement. Examining the Gateway Hypothesis, pp. 65–89. Cambridge: Cambridge University Press.
KandelD. B., YamaguchiK. & ChenK. (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. Journal of Studies on Alcohol, 53, 447–457.
Kandel, D., Chen, K., Warner, L. A., Kessler, R. C. & Grant, B. (1997). Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the US population. Drug & Alcohol Dependence, 44, 11–29.
Kanof, P. D., Aronson, M. J. & Ness, R. (1993). Organic mood syndrome associated with detoxification from methadone maintenance. American Journal of Psychiatry, 150, 423–428.
Karch, S. B. (2009). Karch's Pathology of Drug Abuse, 4th edn. Boca Raton: CRC Press.
Kaye, S., Darke, S. & Finlay-Jones, R. (1998). The onset of heroin use and criminal behaviour: does order make a difference?Drug and Alcohol Dependence, 53, 79–86.
Kaye, S., McKetin, R., Duflou, J. & Darke, S. (2007). Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction, 102, 1204–1211.
Kelly, E., Darke, S. & Ross, J. (2004). A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug and Alcohol Review, 23, 319–344.
Kelly, T. M., Cornelius, J. R. & Clark, D. B. (2004). Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and Alcohol Dependence, 73, 87–97.
Kendler, K. S. & Prescott, C. A. (1998). Cocaine use, abuse and dependence in a population-based sample of female twins. British Journal of Psychiatry, 173, 345–350.
Kendler, K. S., Jacobson, K. C., Prescott, C. A. & Neale, M. C. (2003). Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. American Journal of Psychiatry, 160, 687–695.
Kerr, T.,Oleson, M.,Tyndall, M. W.,Montaner, J. & Wood, E. (2005). A description of a peer-run supervised injection site for injecting drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82, 267–275.
Kerr, T., Fairbairn, N., Tyndall, M.et al. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence, 87, 39–45.
Kessler, R. C. & Wang, P. S. (2008). The descriptive epidemiology of commonly occurring mental disorders in the United States. Annual Review of Public Health, 29, 15–129.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R. & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593–602.
Khantzian, E. J. & Treece, C. (1985). DSM-III psychiatric diagnosis of narcotic addicts. Archives of General Psychiatry, 42, 1067–1071.
Kidorf, M., Disney, E. R., King, V. L., Neufeld, K., Beilenson, P. L. & Brooner, R. K. (2004). Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence, 74, 115–122.
Kimber, J., MacDonald, M., Van Beek, I.et al. (2003). The Sydney Medically Supervised Injecting Centre: client characteristics and predictors of frequent attendance during the first 12 months of operation. Journal of Drug Issues, 33, 639–648.
Kintz, P. (2001). Deaths involving buprenorphine: a compendium of French cases. Forensic Science International, 121, 65–69.
Kirchmayer, U., Davoli, M., Verster, A. D., Amato, L., Ferri, M. & Perucci, C. A. (2002). A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction, 97, 1241–1249.
Knutson, J., DeGarmo, D. & Reid, J. (2004). Social disadvantage and neglectful parenting as precursors to the development of antisocial and aggressive child behavior: testing a theoretical model. Aggressive Behavior, 30, 187–205.
Kosarac, B., Fox, A. A. & Collard, C. D. (2009). Effect of genetic factors on opioid action. Current Opinion in Anaesthesiology, 22, 476–482.
Kotler, P. & Zaltman, G. (1971). Social marketing: an approach to planned social change. Journal of Marketing, 35, 3–12.
Kral, A. H., Wenger, L., Carpenter, L.,Wood, E., Kerr, T. & Bourgois, P. (2010). Acceptability of a safer injection facility among injection drug users in San Francisco. Drug and Alcohol Dependence, 110, 160–163.
Kriegstein, A. R., Shungu, D. C., Millar, W. S.et al. (1999). Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (“chasing the dragon”). Neurology, 53, 1765–1773.
Kritz, S., Chu, M., John-Hull, C., Madray, C., Louie, B. & Brown, L. S. (2009). Opioid dependence as a chronic disease: the interrelationships between length of stay, methadone dose, and age on treatment outcome at an urban opioid treatment program. Journal of Addictive Diseases, 28, 53–56.
Kronstrand, R., Grundin, R. & Jonsson, J. (1998). Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Science International, 92, 29–38.
Kunøe, N., Lobmaier, P., Vederhus, J. K.et al. (2009). Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial. The British Journal of Psychiatry, 194, 541–546.
Lachman, M., Fann, C. S. J., Bartzis, M.et al. (2007) Genomewide suggestive linkage of opioid dependence to chromosome 14q. Human Molecular Genetics, 16, 1327–1334.
Laslett, A. M., Dietze, P. & Dwyer, R. (2008). The oral health of street-recruited injecting drug users: prevalence and correlates of problems. Addiction, 103, 1821–1825.
Lau, J. T. F, Kim, J. H., Tsui, H. Y., Cheung, A., Lau, M. & Yu, A. (2005). The relationship between physical maltreatment and substance use among adolescents: a survey of 95,788 adolescents in Hong Kong. Journal of Adolescent Health, 37, 110–119.
Lemstra, M., Bennett, N. R.,Neudorf, C.et al. (2008). A meta-analysis of marijuana and alcohol use by socio-economic status in adolescents aged 10–15 years. Canadian Journal of Public Health, 99, 172–177.
Lenton, S. R. & Hargreaves, K. M. (2000). Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?Medical Journal of Australia, 173, 260–263.
Lenton, S., Dietze, P., Degenhardt, L., Darke, S. & Butler, T. G. (2009). Now is the time to take steps to allow peer access for heroin overdose in Australia. Drug and Alcohol Review, 28, 583–585.
Li, Y., Ye, L., Jin-Song, P.et al. (2007). Morphine inhibits intrahepatic interferon-α expression and enhances complete hepatitis C virus replication. The Journal of Infectious Diseases, 196, 719–730.
Ling, W., Charuvastra, C., Collins, J. F.et al. (1998). Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93, 475–486.
Lintzeris, N., Mitchell, T. B., Bond, A. J., Nestor, L. & Strang, J. (2006). Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. Journal of Clinical Psychopharmacology, 26, 274–283.
Lintzeris, N., Mitchell, T. B., Bond, A. J., Nestor, L. & Strang, J. (2007). Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Drug and Alcohol Dependence, 91, 187–194.
Lintzeris, N.,Gowing, L. & Bell, J. (2009). Services for heroin withdrawal. In R. P. Mattick., R. Ali & N. Lintzeris. (eds.) Pharmacotherapies for the Treatment of Opioid Dependence. Efficacy, Cost-effectiveness, and Implementation Guidelines, pp. 54–106. New York: Informa Healthcare.
Lipman, E. L., Boyle, M. H., Dooley, M. D. & Offord, D. R. (2002). Child well-being in single mother families. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 75–82.
Löbmann, R. & Verthein, U. (2009). Explaining the effectiveness of heroin-assisted treatment on crime reductions. Law and Human Behavior, 33, 83–95.
Loeber, R., Southamer-Lober, M. & White, H. (1999) Developmental aspects of delinquency and internalising problems and their association with persistent juvenile substance use between ages 7 and 18. Journal of Clinical Child Psychology, 28, 322–332.
Lofwall, M. R., Brooner, R. K., Bigelow, G. E., Kindbom, K. & Strain, E. C. (2005). Characteristics of older opioid maintenance patients. Journal of Substance Abuse Treatment, 28, 265–272.
Lubman, D. I., Yücel, M. & Hall, W. D. (2007). Substance use and the adolescent brain: a toxic combination?Journal of Psychopharmacology, 21, 794.
Lucas, J., Goldfeder, L. B. & Gill, J. R. (2002). Bodies found in the waterways of New York City. Journal of Forensic Science, 47, 137–141.
Luthar, S. S., Merikangas, K. R. & Rounsaville, B. J. (1993). Parental psychopathology and disorders in offspring. A study of relatives of drug abusers. Journal of Nervous and Mental Disease, 181, 351–357.
Luthar, S. S., Cushing, G. & Rounsaville, B. J. (1996). Gender differences among opioid abusers: pathways to disorder and profiles of psychopathology. Drug and Alcohol Dependence, 43, 179–189.
Luthar, S. S., Cicchetti, D. & Becker, B. (2000). The construct of resilience: a critical evaluation and guidelines for future work. Child Development, 71, 543–562.
Luty, J. S. (2003). Social problems, psychological well-being, and childhood parenting experiences in a community sample of heroin addicts in central London. Substance Use and Misuse, 38, 201–219.
Lynskey, M. T. & Fergusson, D. (1995). Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. Journal of Abnormal Child Psychology, 23, 281–301.
Lynskey, M. & Hall, W. (1998). Cohort trends in age of initiation to heroin use. Drug and Alcohol Review, 3, 289–297.
Lynskey, M. & Hall, W. (2000). The effects of adolescent cannabis use on educational attainment: a review. Addiction, 95, 1621–1630.
Lynskey, M. T., Fergusson, D. & Horwood, L. J. (1994). The effects of parental alcohol problems on rates of adolescent psychiatric disorders. Addiction, 89, 1277–1286.
Lynskey, M., Degenhardt, L. & Hall, W. (2000). Cohort trends in youth suicide in Australia. Australian and New Zealand Journal of Psychiatry, 34, 408–412.
Maher, L., Swift, W. & Dawson, M. (2001). Heroin purity and composition in Sydney, Australia. Drug and Alcohol Review, 20, 439–448.
Maher, L., Dixon, D., Hall, W. & Lynskey, M. (2002). Crime and income generation by heroin users. Australian and New Zealand Journal of Criminology, 35, 187–202.
Maloney, E., Degenhardt, L., Darke, S. & Nelson, E. C. (2009). Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates. Addictive Behaviors, 34, 723–729.
Maloney, E., Degenhardt, L., Darke, S. & Nelson, E. C. (2010). Investigating the co-occurrence of self-mutilation and suicide attempts among opioid dependent individuals. Suicide and Life-Threatening Behavior, 40, 50–62.
Man, L. H., Berst, D., Gossop, M., Noble, A. & Strang, J. (2002). Risk of overdose: do those who witness most overdoses also experience most overdoses?Journal of Substance Use, 7, 136–140.
Manfredi, R., Sabbatani, S. & Agostini, D. (2006). Trend of mortality observed in a cohort of drug addicts of the metropolitan area of Bologna, North-Eastern Italy, during a 25-year-period. Collegium Antropologicum, 30, 479–488.
Manzoni, P., Brochu, S., Fischer, B. & Rehm, J. (2006). Determinants of property crime among illicit opiate users outside of treatment across Canada. Deviant Behavior, 27, 351–376.
Mark, T. L., Woody, G. E., Juday, T. & Kleber, H. D. (2001) The economic costs of heroin addiction in the United States. Drug and Alchol Dependence, 61, 195–206.
Martyres, R. F., Clode, D. & Burns, J. M. (2004). Seeking drugs or seeking help? Escalating ‘doctor shopping’ by young heroin users before fatal overdose. Medical Journal of Australia, 180, 211–214.
Marzuk, P., Tardiff, K., Leon, A.et al. (1997). Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: an ecological study. American Journal of Drug and Alcohol Abuse, 23, 221–228.
Masten, A. S. & Obravidic, J. (2006). Competence and resilience in development. Annals of the New York Academy of Sciences, 1094, 13–27.
Mathers, B., Degenhardt, L., Phillips, B.et al. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet, 372, 1733–1745.
Mattick, R. P., Ali, R. & Lintzeris, N. (eds.) (2009). Pharmacotherapies for the Treatment of Opioid Dependence. Efficacy, Cost-effectiveness, and Implementation Guidelines. New York: Informa Healthcare.
Mayer, P. & Hollt, V. (2006). Pharmacogenetics of opioid receptors and addiction. Pharmacogenetics and Genomics, 16, 1–7.
Maxwell, J. C., Pullum, T. W. & Tannert, K. (2005). Deaths of clients in methadone treatment in Texas, 1994–2002. Drug and Alcohol Dependence, 78, 73–81.
McBride, N. (2003). A systematic review of school drug education. Health Education Research: Theory and Practice, 18, 729–742.
McCool, R. M. & Richter, K. P. (2003). Why do so many drug users smoke?Journal of Substance Abuse Treatment, 25, 43–49.
McGlothlin, W. H. & Anglin, M. D. (1981). Long-term follow-up of clients of high- and low-dose methadone programs. Archives of General Psychiatry, 38, 1055–1063.
McGregor, C., Darke, S., Christie, P. & Ali, R. (1998). Experience of non-fatal overdose among heroin users in Adelaide: circumstances and risk perception. Addiction, 93, 701–711.
McGregor, C., Ali, R., Christie, P. & Darke, S. (2001). Overdose among heroin users: evaluation of an intervention in South Australia. Addiction Research, 9, 481–501.
McKetin, R., McLaren, J., Kelly, E., Lubman, D. & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473–1478.
Meader, N. (2010). A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug and Alcohol Dependence, 108, 110–114.
Medina, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J. & Tapert, S. F. (2007). Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicology and Tetratology, 29, 141–152.
Medrano, M. A., Zule, W. A., Hatch, J. & Desmond, D. P. (1999). Prevalence of childhood trauma in a community sample of substance-abusing women. American Journal of Drug and Alcohol Abuse, 25, 449–462.
Miech, R., Chilcoat, H. & Harder, V. (2005). The increase in the association of education and cocaine use over the 1980s and 1990s: evidence for a ‘historical period’ effect. Drug and Alcohol Dependence, 79, 311–320.
Miller, C. L., Kerr, T., Strathdee, S. A., Li, K. & Wood, E. (2007). Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduction Journal, 4, 1–7.
Milloy, M. J. S., Kerr, T., Mathias, R.et al. (2008). Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. American Journal of Drug and Alcohol Abuse, 34, 499–509.
Mills, K. L., Teesson, M., Darke, S., Ross, J. & Lynskey, M. (2004). Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 27, 67–73.
Mills, K., Lynskey, M., Teesson, M., Ross, J. & Darke, S. (2005). Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug and Alcohol Dependence, 77, 243–249.
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U. & Verster, A. (2006). Naltrexone maintenance treatment for opioid dependence. The Cochrane Database of Sytematic Reviews. Jan 25; (1): CD001333.
Miotto, K., McCann, M. J., Rawson, R. A., Frosch, D. & Ling, W. (1997). Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence, 45, 131–134.
Molnar, B., Buka, S. & Kessler, R. (2001). Child sexual abuse and subsequent psychopathology: results from the National Comorbidity Survey. American Journal of Public Health, 91, 753–760.
Morgan, C. J., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J. & Curran, H. V. (2010). Harms associated with psychoactive substances: findings from the UK National Drug Survey. Journal of Psychopharmacology, 24, 147–153.
Morral, A. R., McCaffrey, D. F. & Paddock, S. M. (2002). Reassessing the marijuana gateway effect. Addiction, 97, 1493–1504.
Muntaner, C., Eaton, W. W., Dialai, C., Kessler, R. C. & Sorlie, P. D. (1998). Social class, assets, organizational control and the prevalence of common groups of psychiatric disorders. Social Science and Medicine, 47, 2043–2053.
Murray, C. J. L. & Lopez, A. D. (1997). Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349, 1269–1276.
Najman, J., Toloo, G. & Williams, G. M. (2008). Increasing socio-economic inequalities in drug-induced deaths in Australia: 1981–2002. Drug and Alcohol Review, 27, 613–618.
Nandi, A., Glass, T. A., Cole, S. R. (2010). Neighborhood poverty and injection cessation in a sample of injection drug users. American Journal of Epidemiology, 171, 391–398.
National Institute on Alcohol Abuse and Alcoholism. (2004/5). The effects of alcohol on physiological processes and biological development. Alcohol Research and Health, 28, 125–131.
Neaigus, A., Miller, M., Friedman, S.et al. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction, 96, 847–860.
Neaigus, A., Gyermathy, A., Miller, M., Frajzngier, V. M., Friedman, S. R. & Des Jarlais, D. C. (2006). Transitions to injecting drug use amongst non-injecting heroin users. Journal of Acquired Immune Deficiency Syndromes, 41, 493–503.
Neale, J. & Robertson, M. (2005). Recent life problems and non-fatal overdose among heroin users entering treatment. Addiction, 100, 168–175.
Neale, J., Bloor, M. & Weir, C. (2005). Problem drug users and assault. International Journal of Drug Policy, 16, 393–402.
Newton, N., Andrews, G., Teesson, M., & Vogl, L. (2009). Delivering prevention for alcohol and cannabis using the internet: a cluster randomised controlled trial. Preventive Medicine, 48, 579–584.
Newton, N., Teesson, M., Vogl, L. & Andrews, G. (2010). Internet-based prevention for alcohol and cannabis use: final results of the Climate Schools course. Addiction, 105, 749–759.
Nixon, K. & McClain, J. A. (2010). Adolescence as a critical window for developing an alcohol use disorder: current findings in neuroscience. Current Opinion in Psychiatry, 23, 227–232.
Noble, A., Best, D., Man, L. H., Gossop, M. & Strang, J. (2002). Self-detoxification attempts among methadone maintenance patients: what methods and what success?Addictive Behaviors, 27, 575–584.
Nunes, E. V., Weissman, M. M., Goldstein, R. B.et al. (1998). Psychopathology of children of parents with opiate dependence and/or major depression. Journal of the American Academy on Child and Adolescent Psychiatry, 37, 1142–1151.
Nurco, D. N., Cisin, I. H. & Balter, M. B. (1981). Addict careers. I. A new typology. International Journal of the Addictions, 16, 1305–1325.
Nutt, D., King, L. A., Saulsbury, W. & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369, 1047–1053.
Nutt, D., King, L. A. & Phillips, L. D. (2010). Drug harms in the UK: a multicriteria analysis. Lancet, 376, 1558–1565.
Ochoa, K.C., Hahn, J. A., Seal, K. H. & Moss, A. R. (2001). Overdosing among young injection drug users in San Francisco. Addictive Behaviors, 26, 453–460.
Ødegårda, E., Amundsena, E. J. & Kielland, K. B. (2007). Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers – A competing risk approach. Drug and Alcohol Dependence, 89, 176–182.
O'Driscoll, P. T.,McGough, J., Hagan, H., Thiede, H., Critchlow, C. & Alexander, E. R. (2001). Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health, 91, 984–987.
Office of Applied Studies. (2007). 2006 National Survey on Drug Use and Health. Washington: US Department of Health and Human Services.
Oh, H., Yamazaki, Y. & Kawata, C. (1998). Prevalence and a drug use development model for the study of adolescent drug use in Japan. Japanese Journal of Public Health, 45, 870–882.
Ohannessian, C. M., Hesselbrock, V. M., Kramer, J.et al. (2004). Parental substance use consequences and adolescent psychopathology. Journal of Studies on Alcohol, 65, 725–730.
Oliver, P., Horspool, M. & Keen, J. (2005). Fatal opiate overdose following regimen changes in naltrexone treatment. Addiction, 100, 560–561.
Ompad, D. C., Ikeda, R. M., Shah, N.et al. (2005). Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health, 95, 703–709.
Oppenheimer, E., Tobutt, C., Taylor, C. & Andrew, T. (1994). Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction, 89, 1299–1308.
Orti, R. M., Domingo-Salvany, A., Munoz, A., MacFarlane, D., Suelves, J. M. & Anto, J. M. (1996). Mortality trends in a cohort of opiate addicts, Catalona, Spain. International Journal of Epidemiology, 25, 545–553.
Ouimette, P., Kimerling, R., Shaw, J. & Moos, R. (2000). Physical and sexual abuse among women and men with substance use disorders. Alcoholism Treatment Quarterly, 18, 7–17.
Oviedo-Joekes, E., Marchand, K., Guh, D.et al. (2011). History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. Addictive Behaviors, 36, 55–60.
Patterson, S., Lennings, C. J. & Davey, J. (2000). Methadone clients, crime, and substance use. International Journal of Offender Therapy and Comparative Criminology, 44, 667–680.
Patton, G., Bond, L., Butler, H. & Glover, S. (2003). Changing schools, changing health? Design and implementation of the Gatehouse project. Journal of Adolescent Health, 33, 231–239.
Paulozzi, L. J. (2006) Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. American Journal of Public Health, 96, 1755–1757.
Perez-Jimenez, J. P. & Robert, M. S. (1997). Transitions in the route of heroin use. European Addiction Research, 3, 93–98.
Perkonigg, A., Pfister, H., Höfler, M.et al. (2006). Substance use and substance use disorders in a community sample of adolescents and young adults: incidence, age effects and patterns of use. European Addiction Research, 12, 187–196.
Perneger, T. V., Giner, F., del Rio, M. & Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13–18.
PetronisK. R. & Anthony, J. C. (2003). A different kind of contextual effect: geographical clustering of cocaine incidence in the USA. Journal of Epidemiology and Community Health, 57, 893–900.
Phillips, G. T., Gossop, M. & Bradley, B. (1986). The influence of psychological factors on the opiate withdrawal syndrome. British Journal of Psychiatry, 149, 235–238.
Phillips, S., Matusko, J. & Tomasovic, E. (2007). Reconsidering the relationship between alcohol and lethal violence. Journal of Interpersonal Violence, 1, 66–84.
Plotzker, R. E., Metzger, D. S. & Holmes, W. C. (2007). Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway. The American Journal on Addictions, 16, 431–438.
Pollack, H. & Heimer, R. (2004). The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and hepatitis C. In J. Jager., W. Limburg., M. Kretzschmar., M. Postma & L. Wiessing. (eds.) Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options. EMCDDA Monograph7, pp. 345–370. Luxembourg: Office for Official Publications of the European Communities.
Potterat, J. J., Rothenberg, R. B., Muth, S. Q., Darrow, W. W. & Phillips-Plummer, L. (1998). Pathways to prostitution: the chronology of sexual and drug abuse milestones. Journal of Sex Research, 35, 333–340.
Poulton, R., CaspiA., MilneB. J.et al. (2002). Association between children's experience of socioeconomic disadvantage and adult health: a life-course study. Lancet, 360, 1640–1645.
Powis, B., Griffiths, P., Gossop, M. & Strang, J. (1996). The differences between male and female drug users: community samples of heroin and cocaine users compared. Substance Use and Misuse, 31, 529–543.
Powis, B., Strang, J., Griffiths, P.et al. (1999). Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction, 94, 471–478.
Preti, A., Miotto, P. & De Coppi, M. (2002). Deaths by unintentional illicit drug overdose in Italy, 1984–2000. Drug and Alcohol Dependence, 66, 275–282.
Prochaska, J. O. & Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health, Promotion, 12, 38–48.
Prochaska, J. O., DiClemente, C. C., Velicer, W. F., Ginpil, S. & Norcross, J. C. (1985). Predicting change in smoking status for self-changers. Addictive Behaviors, 10, 395–406.
Pugatch, D., Strong, L. L., Has, P.et al. (2001). Heroin use in adolescents and young adults admitted for drug detoxification. Journal of Substance Abuse, 13, 337–346.
Quaglio, G., Talamini, G., Lechi, A.et al. (2001). Study of heroin-related deaths in north-eastern Italy 1985–98 to establish main causes of death. Addiction, 96, 1127–1137.
Quan, V., Vongchak, T., Jittiwutikan, J.et al. (2007). Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand. Addiction, 102, 441–446.
Rajaratnam, R., Sivesind, D., Todman, M., Roane, D. & Seewald, R. (2009). The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. Journal of Opioid Management, 5, 27–37.
Rathod, N. H., Addenbrooke, W. M. & Rosenbach, A. F. (2005). Heroin dependence in an English town: 33-year follow-up. British Journal of Psychiatry, 187, 421–425.
Ravndal, E. & Amundsen, E. J. (2010). Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug and Alcohol Dependence, 108, 65–69.
Ravndal, E., Lauritzen, G., Jansson, S. O., Larsson, J. (2001). Childhood maltreatment among Norwegian drug abusers in treatment. International Journal of Social Welfare, 10, 142–147.
Reece, A. S. (2007). Dentition of addiction in Queensland: poor dental status and major contributing drugs. Australian Dental Journal, 52, 144–149.
Reed, L. J.,Glasper, A., de Wet, C. J., Bearn, J. & Gossop, M. (2007). Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?Journal of Clinical Psychopharmacology, 27, 188–192.
Rehm, J.,
Gschwend, P.,
Steffen, T.,
Gutzwiller, F.,
Dobler-Mikola, A. &
Uchtenhagen, A. (
2001). Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.
The Lancet,
358, 1417–1420.
http://www.sciencedirect.com/science/journal/01406736358 Rehm, J., Frick, U., Hartwig, C., Gutzwiller, F., Gschwend, P. & Uchtenhagen, A. (2005). Mortality in heroin-assisted treatment in Switzerland 1994–2000. Drug and Alcohol Dependence, 79, 137–143.
Rehm, J., Baliunas, D., Brochu, S.et al. (2006). The Cost of Subsance Abuse in Canada 2002. Ottawa: Canadian Centre on Substance Abuse.
Risser, D., Uhl, A., Stichenwirth, M.et al. (2000). Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction, 95, 375–382.
Roberts, A., Mathers, B., Howard, J. & Degenhardt, L. (2010). Women Who Inject Drugs: A Review of their Risks, Experiences and Needs. Sydney: University of New South Wales.
Robertson, J. R., Ronald, P. J. M., Raab, G., Ross, A. J. & Parpia, T. (1994). Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. British Medical Journal, 309, 369–372.
Robins, L. N. (1993). Vietnam veterans’ rapid recovery from heroin addiction: a fluke or normal expectation?Addiction, 88, 1041–1054.
Rosen, D., Smith, M. L. & Reynolds, C. F. (2008). The prevalence of mental and physical health disorders among older methadone patients. American Journal of Geriatric Psychiatry, 16, 488–497.
Rosen, S., Ouimette, P. C., Sheikh, J. I., Gregg, J. A. & Moos, R. H. (2002). Physical and sexual abuse history and addiction treatment outcomes. Journal of Studies on Alcohol, 63, 683–687.
Ross, J. & Darke, S. (2000). The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction, 95, 1785–1793.
Ross, J., Darke, S. & Hall, W. (1997). Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction, 92, 697–705.
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A. & Cooke, R. (2005). The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 24, 411–418.
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A. & Cooke, R. (2006). Short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders and Their Treatment, 5, 133–144.
Rossow, I. (1994). Suicide among drug addicts in Norway. Addiction, 89, 1667–1673.
Rossow, I. & Lauritzen, G. (1999). Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction, 94, 209–219.
Rossow, I. & Lauritzen, G. (2001). Shattered childhood: a key issue in suicidal behavior among drug addicts. Addiction, 96, 227–240.
Rothenberg, J. L., Sullivan, M. A., Church, S. H.et al. (2002). Behavioral naltrexone therapy: An integrated treatment for opiate dependence. Journal of Substance Abuse Treatment, 23, 351–360.
Rothman, R. A. & Stephens, R. S. (eds.) (2006). Cannabis Dependence. Its Nature, Consequences and Treatment. Cambridge: Cambridge University Press.
Rounsaville, B. J., Kosten, T. & Kleber, H. (1985). Success and failure at outpatient opioid detoxification: evaluating the process of clonidine- and methadone-assisted withdrawal. Journal of Nervous and Mental Disease, 173, 103–110.
Rouser, E., Brooner, R. K., Regier, M. W. & Bigelow, G. E. (1994). Psychiatric distress in antisocial drug abusers: relation to other personality disorders. Drug Alcohol Dependence, 34, 149–154.
Roxburgh, A., Hall, W. D., Degenhardt, L.et al. (2010). Trends in cannabis use and cannabis-related harm in Australia 1993–2007, Addiction, 105, 1071–1079.
Roy, A. (2002). Characteristics of opiate dependent patients who attempt suicide. Journal of Clinical Psychiatry, 63, 403–407.
Roy, A. (2010). Risk factors for attempting suicide in heroin addicts. Suicide and Life-Threatening Behavior, 40, 416–420.
Roy, E., Haley, N., Leclerc, P., Cédras, L. & Boivin, J-F. (2002). Drug injection among street youth: the first time. Addiction, 97, 1003–1009.
Rutherford, M. J., Cacciola, J. S. & Alterman, A. I. (1994). Relationships of personality disorders with problem severity in methadone patients. Drug and Alcohol Dependence, 35, 69–76.
Ruttenber, A. J. & Luke, J. L. (1984). Heroin-related deaths: new epidemiologic insights. Science, 226, 14–20.
Ruttenber, A. J., Kalter, H. O. & Santinga, P. (1990). The role of ethanol abuse in the etiology of heroin-related death. Journal of Forensic Sciences, 35, 891–900.
Salamina, G., Diecidue, R., Vigna-Taglianti, F.et al. (2010). Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Substance Use and Misuse, 45, 2076–2092.
San, L.,Pomarol, G., Peri, M., Olle, M. & Cami, J. (1991). Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. British Journal of Addiction, 86, 983–990.
Sanchez-Carbonell, J., Cami, J. & Brigo, S. B. (1988). Follow-up of heroin addicts in Spain (EMETYST project): results 1 year after treatment admission, British Journal of Addiction, 83, 1439–1448.
Sanchez-Carbonell, X. & Seus, L. (2000). Ten-year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction, 95, 941–948.
Sansone, R. A., Whitecar, P. & Wiederman, M. W. (2009). The prevalence of childhood trauma among those seeking buprenorphine treatment. Journal of Addictive Diseases, 28, 64–67.
Santelli, J. S., Kaiser, J., Hirsch, L., Radosh, A., Simkin, L. & Middlestadt, S. (2004). Initiation of sexual intercourse among middle school adolescents: the influence of psychosocial factors. Journal of Adolescent Health, 34, 200–208.
Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005). Genetic determinants of addiction to opioids and cocaine. Harvard Review of Psychiatry 13, 218–232.
Schaar, I. & Ojehagan, A. (2001). Severely ill substance abusers: an 18-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, 36, 70–78.
Scherbaum, N., Specka, M., Hauptmann, G. & Gastpar, M. (2002). Does maintenance treatment reduce the mortality rate of opioid addicts?Fortschritte der Neurologie-Psychiatrie, 70, 455–61.
Schmittner, J., Schroeder, J. R., Epstein, D. H.& Preston, K. L. (2005). Menstrual cycle length during methadone maintenance. Addiction, 100, 829–836.
Schmucker, D. L. (2005). Age-related changes in liver structure and function: implications for disease?Experimental Gerontology, 40, 650–659.
Seal, K. H., Kral, A. H., Gee, L.et al. (2001). Prediction and prevention of non-fatal overdose among street-recruited injection heroin users in the San Francisco Bay area, 1998–1999. American Journal of Public Health, 91, 1842–1846.
Seal, K. H., Thawley, R., Gee, L.et al. (2005). Naloxone distribution and cardiopulmonary resuscitaion training for injection drug users to prevent heroin overdose death: a pilot intervention. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82, 303–311.
Sergeev, B., Karpets, A., Sarang, A. & Tikhonov, M. (2003). Prevalence and circumstances of opiate overdose among injection drug users in the Russian federation. Journal of Urban Health, 80, 212–219.
Seymour, A., Black, M., Jay, J., Cooper, G., Weir, C. & Oliver, J. (2003). The role of methadone in drug-related deaths in the west of Scotland. Addiction, 98, 995–1002.
Sheehan, M., Oppenheimer, E. & Taylor, C. (1988). Who comes for treatment. Drug misusers at three London agencies. British Journal of Addiction, 83, 311–320.
Sheehan, M.,Oppenheimer, E. & Taylor, C. (1993). Opiate users and the first years after treatment: outcome analysis of the proportion of follow-up time spent in abstinence. Addiction, 88, 1679–1689.
Shields, L. B. E., Hunsaker, D. M., Hunsaker, J. C. & Ward, M. K. (2006). Toxicologic findings in suicide. A 10-year retrospective review of Kentucky medical examiner cases. American Journal of Forensic Medicine and Pathology, 27, 106–112.
Shrier, L. A., Harris, S. K., Sternberg, M. & Beardslee, W. R. (2001). Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Preventive Medicine, 33, 179–189.
Simini, B. (1998). Naloxone supplied to Italian heroin addicts. The Lancet, 352, 967.
Simpson, D. D. & Sells, S. B. (1982). Effectiveness of treatment for drug abuse: an overview of the DARP research program. Advances in Substance Abuse, 2, 27–29.
Simpson, D. D. & Sells, S. B. (eds.) (1990). Opioid Addiction and Treatment: A 12-Year Follow-up. Florida: Robert E. Kreiger Publishing.
Simpson, D. D., Joe, G. W. & Brown, B. S. (1997). Treatment retention and follow-up outcomes. The Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 4, 294–307.
Simons, L. & Giorgio, T. (2008). Characteristics of substance abusing men and women entering a drug treatment program. An exploration of sex differences. Addictive Disorders and Their Treatment, 7, 15–23.
Slade, T., Johnston, A., Browne, O., Andrews, G. & Whiteford, H. (2009). 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Australian and New Zealand Journal of Psychiatry, 43, 594.
Smolka, M. & Schmidt, L. G. (1999). The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction, 94, 1191–1198.
Smyth, B. P., O'Brien, M. & Barry, J. (2000). Trends in treated opiate misuse in Dublin: the emergence of chasing the dragon. Addiction, 95, 1217–1223.
Smyth, B., Hoffman, V., Fan, J. & Hser, Y. (2007). Years of potential life lost among heroin addicts 33 years after treatment. Preventative Medicine, 44, 369–374.
Soyka, M., Apelt, S., Lieb, M. & Wittchen, H. (2006). One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients. Journal of Clinical Psychopharmacology, 26, 657–660.
Spijkerman, I. J. B., Koot, M., Prins, M.et al. (1995). Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS, 9, 1085–1092.
Spittal, P. M., Bruneau, J., Craib, K. J. P.et al. (2003). Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care, 15, 187–195.
Spooner, C. & Hetherington, K. (2005). Social Determinants of Drug Use. National Drug and Alcohol Research Centre Technical Report No. 228. Sydney: University of New South Wales.
Stafford, J., Sindicich, N., Burns, L.et al. (2008). Australian Drug Trends 2008: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 19. Sydney: National Drug and Alcohol Research Centre.
Stapleton, R. D. & Comiskey, C. M. (2010). Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug and Alcohol Dependence, 107, 56–61.
Stenbacka, M., Liefman, L. & Romelsjo, A. (2010). Mortality and cause of death among 1705 illicit drug users, a 37 year follow-up. Drug and Alcohol Review 29, 21–27.
Stewart, D., Gossop, M. & Marsden, J. (2002). Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). Journal of Substance Abuse Treatment, 22, 1–9.
Stewart, L. M., Henderson, C. J., Hobbs, M. T., Ridout, S. C. & Knuiman, M. W. (2004). Risk of death in prisoners after release from jail. Australian and New Zealand Journal of Public Health, 28, 32–36.
Strain, E. C., Stitzer, M. L. & Bigelow, G. E. (1991). Early treatment time course of depressive symptoms in opiate addicts. Journal of Nervous and Mental Disease, 179, 215–221.
Strang, J., Griffiths, P. & Gossop, M. (1997). Heroin smoking by ‘chasing the dragon’: origins and history. Addiction, 92, 673–683.
Strang, J., Griffiths, P., Powis, B. & Gossop, M. (1999a). Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. American Journal of the Addictions, 8, 148–160.
Strang, J., Powis, B., Best, D.et al. (1999b). Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction, 94, 199–204.
Strang, J., Best, D., Man, L. H., Noble, A. & Gossop, M. (2000). Peer-initiated resuscitation: fellow drug users could be mobilised to implement resuscitation. International Journal of Drug Policy, 11, 437–445.
Strang, J., McCambridge, J., Best, D.et al. (2003). Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. British Medical Journal, 356, 959–960.
Strassels, S. A. (2009). Economic burden of prescription opioid misuse and abuse. Journal of Managed Care Pharmacy, 15, 556–562.
Stueve, A. & O'Donnell, L. N. (2005). Alcohol initiation and subsequent sexual and alcohol risk behaviors among urban youths. American Journal of Public Health, 95, 887–893.
Surratt, H. L., Inciardi, J. A., Kurtz, S. P. & Kiley, M. C. (2004). Sex work and drug use in a subculture of violence. Crime and Delinquency, 50, 43–59.
Swift, W., Maher, L., Sunjic, S. & Doan, V. (1999). Transitions between routes of heroin administration: a study of Caucasian and Indo-Chinese heroin users in south-western Sydney, Australia. Addiction, 94, 71–82.
Tagliaro, F., Debattisti, Z., Smith, F. P. & Marigo, M. (1998). Death from heroin overdose: findings from hair analysis. Lancet, 351, 1923–1925.
Tardiff, K., Wallace, Z., Tracy, M., Piper, T. M., Vlahov, D. & Galla, S. (2005). Drug and alcohol use as determinants of New York city homicide trends from 1990 to 1998. Journal of Forensic Science, 50, 470–474.
Teesson, M., Havard, A., Fairbairn, S., Ross, J., Lynskey, M. & Darke, S. (2005). Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Dependence, 78, 309–315.
Teesson, M., Havard, A., Ross, J. & Darke, S. (2006a). Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 25, 241–247.
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Cooke, R. & Ritter, A. (2006b). The Australian Treatment Outcome Study (ATOS): 1 year follow-up results. Drug and Alcohol Dependence, 83, 174–180.
Teesson, M., Mills, K. L., Ross, J., Darke, S., Williamson, A. & Havard, A. (2008). The impact of treatment on 3 year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction, 103, 80–88.
Teesson, M., Hall, W.,Slade, T.et al. (in press). Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings from the 2007 National Survey of Mental Health and Wellbeing. Addiction.
Termorshuizen, F., Krol, A., Prins, M. & van Ameijden, E. J. C. (2005). Long-term outcome of chronic drug use: the Amsterdam Cohort Study among drug users. American Journal of Epidemiology, 161, 271–279.
Tobler, N. & Stratton, H. (1997). Effectiveness of school-based drug prevention programs: a meta-analysis of the research. Journal of Primary Prevention, 18, 71–125.
Tobin, K. E. & Latkin, C. A. (2003). The relationship between depressive symptoms and non-fatal overdose among a sample of drug users in Baltimore, Maryland. Journal of Urban Health, 80, 220–229.
Tobin, K. E., Davey, M. A. & Latkin, C. A. (2005). Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates. Addiction, 100, 397–404.
Torok, M., Darke, S., Kaye, S. & Ross, J. (in press). Conduct disorder as a risk factor for violent victimization and offending amongst regular illicit drug users. Journal of Drug Issues.
Trémeau, F. A. D., Staner, L., Corrêa, H.et al. (2008). Suicidality in opioid-dependent subjects. The American Journal on Addictions, 17, 187–194.
Triffleman, E. G., Marmar, C. R., Delucchi, K. L. & Ronfeldt, H. (1995). Childhood trauma and posttraumatic stress disorder in substance abuse inpatients. Journal of Nervous and Mental Disease, 183, 172–176.
Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J. & Burr, R. (2000). Borderline personality disorder and substance use disorders: a review and integration. Clinical Psychology Review, 20, 235–253.
Tucker, T. K., Ritter, A., Maher, C. & Jackson, H. (2004). Naltrexone maintenance for heroin dependence: uptake, attrition and retention. Drug and Alcohol Review, 23, 299–309.
Turk, E. E. & Tsokos, M. (2004). Pathologic features of fatal falls from height. American Journal of Forensic Medicine and Pathology, 25, 194–199.
Tyndall, M. W., Craib, K. J. P., Currie, S., Li, K., O'Shaughnessy, M. V. & Schechter, M. T. (2001). Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes, 28, 351–357.
Tyrfingsson, T., Thorgeirsson, T. E., Geller, F.et al. (2010). Addictions and their familiality in Iceland. Annals of The New York Academy of Sciences, 1187, 208–217.
United Nations Office of Drug Control (2009). World Illict Drug Report 2009. New York: United Nations Publications.
Vaillant, G. (1973). A 20 year follow-up of New York narcotic addicts. Archives of General Psychiatry, 29, 237–241.
van Ameijden, E. J. C., van den Hoek, J. A. R., Hartgers, C. & Coutinho, R. A. (1994). Risk factors for the transition from non-injection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology, 139, 1153–1163.
van Amsterdam, J., Opperhuizen, A., Koeter, M. & van den Brink, W. (2010). Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. European Addiction Research, 16, 202–207.
van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W. J., van Zwieten, B. J. & van Ree, J. M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. British Medical Journal, 327, 310–315.
Van der Zanden, B. P., Dijkgraaf, M. G.Blanken, P., van ReeJ. M. & van den Brink, W. (2007). Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. Drug and Alcohol Dependence, 86, 84–90.
Van Etten, M. L. & Anthony, J. C. (1999). Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug and Alcohol Dependence, 54, 117–125.
Van Gundy, K. & Rebellon, C. J. (2010). A life-course perspective on the ‘Gateway Hypothesis’. Journal of Health and Social Behavior, 51, 244–259.
van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R. & Verdoux, H. (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology, 156, 319–327.
van Ours, J. C. (2003). Is cannabis a stepping-stone for cocaine?Journal of Health Economics, 22, 539–554.
van Ours, J. & Williams, J. (2009). Why parents worry: initiation into cannabis use by youth and their educational attainment. Journal of Health Economics, 28, 132–142.
Velleman, R., Templeton, L. & Copello, A. (2005). The role of the family in preventing and intervening with substance use and misuse: a comprehensive review of family interventions, with a focus on young people. Drug and Alcohol Review, 24, 93–109.
Vidal-Trecan, G., Varescon-Pousson, I. & Boissonnas, A. (2002). Injection risk behaviors at the first and at the most recent injections among drug users. Drug and Alcohol Dependence, 66, 107–109.
Vidal-Trecan, G., Varescon, I., Nabet, N. & Boissonnas, A. (2003). Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug and Alcohol Dependence, 69, 175–181.
Vimpani, G. (2005). Getting the mix right: family, community and social policy interventions to improve outcomes for young people at risk of substance misuse. Drug and Alcohol Review, 24, 111–125.
Vlahov, D. & Junge, B. (1998). The role of needle exchange programs in HIV prevention. Public Health Reports, 113 (suppl 1), 75–80.
Vlahov, D., Wang, C., Galai, N.et al. (2004). Mortality risk among new onset injection drug users. Addiction, 99, 946–954.
Vlahov, D., Galai, N., Safaeian, M.et al. (2005). Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. American Journal of Epidemiology, 161, 999–1012.
Vlahov, D., Wang, C., Ompad, D.et al. (2008). Mortality risk among recent-onset injection drug users in five US cities. Substance Use and Misuse, 43, 413–428.
Vogl, L., Teesson, M., Andrews, G., Bird, K., Steadman, B. & Dillon, P. (2009). A computerized harm minimization prevention program for alcohol misuse and related harms: randomized controlled trial. Addiction, 104, 564–575.
Wahren, C. A., Brandt, L. & Allebeck, P. (1997). Has mortality in drug addicts increased? A comparison between hospitalized cohorts in Stockholm. International Journal of Epidemiology, 26, 1219–1226.
Ward, J, Mattick, R. P. & Hall, W. (eds.) (1998). Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood.
Warner, L. A., Kessler, R. C., Hughes, M., Anthony, J. C. & Nelson, C. B. (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 52, 219–229.
Warner-Smith, M., Darke, S., Lynskey, M. & Hall, W. (2001). Heroin overdose: causes and consequences. Addiction, 96, 1113–1125.
Warner-Smith, M., Darke, S. & Day, C. (2002). Morbidity associated with non-fatal heroin overdose. Addiction, 97, 963–967.
Weatherburn, D. & Lind, B. (2001). Delinquent-prone Communities. Cambridge: Cambridge University Press.
Weiss, R. D., Mirin, S. M., Griffin, M. L. & Michael, J. L. (1988). Psychopathology in cocaine abusers. Changing trends. Journal of Nervous and Mental Disease, 176, 719–725.
Wells, J. E. & McGee, M. A. (2008). Violations of the usual sequence of drug initiation: prevalence and associations with the development of dependence in the New Zealand Mental Health Survey. Journal of Studies in Alcohol and Drugs, 69, 789–795.
Wells, J. E., Browne, O., Scott, K. M., McGee, M. A., Baxter, J. & Kokaua, J. (2006). Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Australian and New Zealand Journal of Psychiatry, 40, 845–854.
West, R. (2005). Time for a change: putting the transtheroetical (stages of change) model to rest. Addiction, 100, 1036–1039.
West, R. (2006). Theory of Addiction. Oxford: Addiction Press.
Westermeyer, J., Wahmanholm, K. & Thuras, P. (2001). Effects of childhood physical abuse on course and severity of substance abuse. The American Journal on Addictions, 10, 101–110.
White, A. G., Birnbaum, H. G., Mareva, M. N.et al. (2005). Direct costs of opioid abuse in an insured population in the United States. Journal of Managed Care Pharmacy, 11, 469–479.
White, A. M., Truesdale, M. C., Bae, J. G.et al. (2002). Differential effects of ethanol on motor coordination in adolescent and adult rats. Pharmacology, Biochemistry and Behavior, 73, 673–677.
White, D. & Pitts, P. (1998). Educating young people about drugs: a systematic review. Addiction, 93, 1475–1487.
White, J. & Irvine, R. (1999). Mechanisms of fatal opioid overdose. Addiction, 95, 961–972.
Wilcox, H. C., Connor, K. R. & Caine, E. D. (2004). Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug and Alcohol Dependence, 76S, S11–S19.
Wilens, T. E., Biedeman, J., Bredin, E.et al. (2002). A family study of the high-risk children of opioid- and alcohol-dependent parents. The American Journal on Addictions, 11, 41–51.
Wilkinson, R. & Marmot, M. (eds.) (2003). The Solid Facts: Social Determinants of Health, 2nd edn. Copenhagen: Centre for Urban Health, World Health Organization.
Williamson, A., Darke, S., Ross, J. & Teesson, M. (2007). Effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months. Journal of Substance Abuse Treatment, 33, 287–293.
Wines, J. D., Saitz, R., Horton, N. J., Lloyd-Travaglini, C. & Samet, J. (2004). Suicidal behavior, drug use and depressive symptoms after detoxification: a 2 year prospective study. Drug and Alcohol Dependence, 76S, S21–S29.
Wines, J. D., Saitz, R., Horton, N. J., Lloyd-Travaglini, C. & Samet, J. H. (2007). Overdose after detoxification: a prospective study. Drug and Alcohol Dependence, 89, 161–169.
Winick, C. (1962). Maturing out of narcotic addiction. Bulletin on Narcotics, 14, 1–7.
Winick, C. (1964). The life cycle of the narcotic addict and of addiction. Bulletin on Narcotics, 16, 1–11.
Wood, E., Tyndall, M., Zhengou, Q., Zhang, R., Montaner, J. & Kerr, T. (2006). Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. American Journal of Public Health, 96, 770–773.
Wood, E., Lloyd-Smith, E., Li, K.et al. (2007). Frequent needle exchange use and HIV incidence in Vancouver, Canada. The American Journal of Medicine, 120, 172–179.
Wu, N. S., Schairer, L. C., Dellor, E. & Grell, C. (2010). Childhood trauma and health outcomes in adults with comorbid substance abuse and mental health disorders. Addictive Behaviors 35, 68–71.
Yin, L., Qin, G., Ruan, Y.et al. (2007). Non-fatal overdose among heroin users in South-western China. American Journal of Drug and Alcohol Abuse, 33, 505–516.
Zaccarelli, M., Gattari, P., Rezza, G.et al. (1994). Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS, 8, 345–350.
Zador, D., Lyons-Wall, P. M. & Webster, I. (1996). High sugar intake in a group of women on methadone maintenance in south western Sydney. Addiction, 91, 1053–1061.
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I. & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325, 1199.
Zhang, L., Ruan, Y. H., Yang, Z. N.et al. (2005). A 1-year prospective cohort study on mortality of injecting drug users. Chinese Journal of Epidemiology, 26, 190–193.
Ziedonis, D. M., Amass, L., Steinberg, M.et al. (2009). Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multi center trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network. Drug and Alcohol Dependence, 99, 28–36.